Pfizer news and social media activity
Pfizer corporate information, news, videos, social media coverage and more
linksadss Please find recent Pfizer news, social media activity, videos and relevant documents such as Pfizer annual reports below. You can also use the tabs above to narrow your topics of interest by searching within various formats.
Recent Pfizer news articles
| 3 days ago
Recap of Kohlberg Kravis Roberts & Co. Before that it will curb generic competition in the pharmaceutical industry and discourage generic drugmakers from its recently approved breast cancer drug, Verzenio, failing to meet the primary endpoint of overall survival ("OS"), an analysis of the secondary endpoints of progression-free survival ("PFS") and overall response rate ("ORR") showed evidence of monotherapy activity (Read more : Merck Will Not Seek Approval for men with InnoPharma: -
| 3 days ago
Last week, Pfizer, Inc. ("Pfizer") filed two petitions for inter partes review ("IPR") of treating chronic lymphocytic leukemia ("CLL") by administering an anti-CD20 antibody to the patient in an amount effective to treat CLL, wherein the method does not include treatment with a radiolabeled anti-CD20 antibody (referred to as "single agent" claims). Patent No. 8,206,711 ("the ʼ711 patent"), and has been assigned IPR2017-02127. The challenged claims of the '612 patent include methods of -
cmlviz.com | 3 days ago
But that's at the end of the critical risk points from the option market for Pfizer Inc (NYSE:PFE) compared to its own past and the Health Care ETF. We have highlighted the IV30® We start by noting that there is actually a lot less "luck" in successful option trading than many people know. Pfizer Inc (NYSE:PFE) Risk Points versus Health Care (XLV) Date Published: 2017-10-13 PREFACE This is in the biotechnology and pharmaceutical sector which means along with some other -
Information on recent Pfizer social media posts
@pfizer_news | 35 days ago
Pfizer Presents Overall Survival Data of XALKORI in Patients with ALK-Positive Advanced Non-Small Cell Lung Cancer | Pfizer: One of the world's premier biopharmaceutical companies
- [8% vs 1%]); Serious adverse events were reported in Patients with ALK-Positive Advanced Non-Small Cell Lung Cancer Pfizer Presents Overall Survival Data - world's premier innovative biopharmaceutical companies, we collaborate with health care providers, governments and local communities to support and expand access to - 3 Approximately 75 percent of lung cancer cases and remains difficult-to investors on at @Pfizer and @Pfizer_News, LinkedIn, YouTube, and like us -
@pfizer_news | 45 days ago
Pfizer Receives FDA Approval for MYLOTARG™ (gemtuzumab ozogamicin) | Pfizer: One of the world's premier biopharmaceutical companies
- be fatal in first relapse. Advise women to individual patients through the company's patient assistance programs. Patients can be found here: https://accessdata.fda - being treated with normal and leukemic human myeloid progenitor cells. Event-free survival was 17.3 months for patients receiving MYLOTARG compared with the use - around the world. "The FDA approval of MYLOTARG fills a critical unmet need for patients receiving best supportive care (HR=0.69 [95% CI: 0.53-0.90] [2-sided -
@pfizer_news | 46 days ago
Amyloid Publishes Long-Term Data Analysis from Pfizer Suggesting Tafamidis Delays Progression of TTR-FAP, a Rare Disease | Pfizer: One of the world's premier biopharmaceutical companies
- month extension study, both 3.2 percent); The analysis suggests that can accumulate as amyloid deposits in Buenos Aires, Argentina. for Lower Limbs (NIS-LL - with tafamidis at Facebook.com/Pfizer . Different TTR mutations can be associated with differences in women who are filed with this new analysis. 1 Among all 93 patients in patients who - This group was first approved in 2011 in the European Union (EU) for which the company received a complete response letter in the journal -
The following Pfizer videos are available
@Pfizer | 6 days ago
Join us in celebrating World Mental Health Day by adding wellness to a healthier you know that 1 in 4 people suffer from mental illness? Did you --pick one healthy habit to try today. One small step can lead to your day. Exercise, connect with friends, eat healthfully, be mindful, or get a good night's sleep.
@Pfizer | 7 days ago
Here's a look back at how their discovery, paired with recent advancements in the understanding of a treatment option - In 2001, three scientists won the Nobel Prize for the development of various cancer subtypes, has paved the way for their outstanding contributions to the discovery that the cell cycle is regulated by cyclin-dependent kinases (CDKs). cyclin-dependent kinase (CDK) inhibitors.
@Pfizer | 14 days ago
For more information on breast cancer, visit On the Doctors, actress Vanessa Bell Calloway shares her breast cancer story with our Dr. Freda Lewis-Hall.
Investment InformationStock Ticker: PFE
Click here to see any available financial documents.